3 enrolling by invitation. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Enrolling by invitation 3 |
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Fibrosis: new trials by email Literature Review of Fibrosis trials Research Report on Fibrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation Belumosudil 200 mg QD, Placebo - Rejection Chronic Renal | Phase 2 | Enrolling by invitation | The Methodist Hospital Research Institute | 40 | 2025-09-11 | 2025-11-12 |
| A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics Prednisone, UDCA (Ursodeoxycholic acid) - Primary Biliary Cholangitis (PBC) | Phase 2 / Phase 3 | Enrolling by invitation | Han Ying | 244 | 2024-10-30 | 2026-10-29 |
| Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation Fingolimod, Placebo - Interstitial Fibrosis, Kidney Transplant; Complications | Phase 2 | Enrolling by invitation | The Methodist Hospital Research Institute | 20 | 2022-07-28 | 2025-03-14 |
Pulmonary Fibrosis (2) · Kidney Failure, Chronic (1) · Liver Cirrhosis, Biliary (1) · Rejection, Psychology (1)
Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Lung Diseases (2) · Lung Diseases, Interstitial (2) · Respiratory Tract Diseases (2) · Behavior (1) · Bile Duct Diseases (1) · Biliary Tract Diseases (1) · Cholestasis (1) · Cholestasis, Intrahepatic (1) · Chronic Disease (1) · Digestive System Diseases (1) · Disease Attributes (1) · Female Urogenital Diseases (1)
Fingolimod Hydrochloride (1) · Methylcellulose (1) · Prednisone (1) · Ursodeoxycholic Acid (1) · belumosudil (1)
The Methodist Hospital Research Institute (2) · Han Ying (1)
United States (2) · China (1)